PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: a prospective, multicentre, Swiss registry study

The Lancet Medical Imaging & Theranostics · Elsevier

Аннотация

Publication date: September 2026 Source: The Lancet Medical Imaging & Theranostics, Volume 1, Issue 2 Author(s): Alin Chirindel, Niklaus Schaefer, Maria del Sol Pérez Lago, Flavio Forrer, Ali Afshar-Oromieh, Stephan Beintner-Skawran, Andreas Bauman, Michael Coslovsky, Valentin Klotzbuecher, Marine Tissier, Andrea Zander, Ole Maas, Ivette Engel-Bicik, Anja Lorch, Cyrill A Rentsch, Frank Stenner, Arnoud J Templeton, Egbert Nitzsche, Damian Wild, Guillaume P Nicolas

Читать у издателя →

Похожие статьи